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W.B. Campbell,1* S. Elworthy,1 I. Peerlinck,1 K. Vanslembroek,1 R. Bangur,2
D. Stableforth2 and C.D. Sheldon11Royal Devon and Exeter Hospital, Wonford, Exeter EX2 5DW, and 2Birmingham Heartlands Hospital,
Birmingham B9 5SS, UKObjective. To obtain information which might guide vascular specialists and their patients in the choice of site for
implantation of central venous access devices (CVADs).
Design. Questionnaire study.
Methods. Questionnaires were sent to 69 patients with cystic fibrosis and 54 (78%) responded (39 females: age 5–63,
median 24 years). They had received a total of 79 CVADs placed in the upper chest (60), lower chest (13), thigh (3) and arm
(3). Only 46% patients had been offered a choice of site.
Results. Questions about 14 specific areas of disability or concern found problems most frequently with discomfort (54%),
wearing a seatbelt (51%), cosmetic appearance (44%), scarring (44%), choice of clothing (42%) and lying in bed or sleeping
(42%). There were no significant differences between upper and lower chest CVADs. Patients with upper chest CVADs
seldom had any problems with use of their arm (12%). 81%CVADs could not be accessed by the patients, and in 39% of these
cases patients would have liked to do so.
Conclusions. Many patients complain of few problems with their CVADs, regardless of site, but half have some persistent
discomfort. Cosmetic considerations frequently cause concern and patients should be given choice in the site of their CVADs.Keywords: Central venous access; Chemotherapy; Cystic fibrosis; Venous access ports.Introduction
Since the introduction of central venous access devices
(CVADs—specifically those with a subcutaneous port
and tunnelled catheter to a central vein) in the 1980s
increasing numbers have been inserted for treatment
of a variety of conditions, many by both vascular
surgeons and interventional radiologists. There is little
to guide specialists in counselling patients about the
site of CVADs except their personal experience, and
patients may not be offered a choice. Published reports
have tended to concentrate on the function and
medical complications of CVADs rather than patients’
preferences and views.1,2 The available data suggest
that patients may have problems or concerns about
cosmetic appearance, clothing, wearing seatbelts, anding author. W.B. Campbell, Professor and Consultant
al Devon and Exeter Hospital, Wonford, Exeter EX2
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problems and advantages of placing CVADs in
different sites is elusive.4,5 This study was designed
to find out about problems which patients experienced
from CVADs at different sites; about the choices they
had been offered; and about their preferences in the
site of future ports. Patients with cystic fibrosis were
selected as the study population, because their
survival with one or more CVADs in situ is often
prolonged, in contrast to many patients requiring
access for malignant disease, whose duration of
survival is often short.Patients and Methods
Questionnaires were sent to 69 patients with CVADs
under the care of two respiratory units for cystic
fibrosis. Responses were received from 54 (78%
response rate) comprising 39 females and 15 males
(age range 5–63, median 24 years). There were fourEur J Vasc Endovasc Surg 28, 642–644 (2004)
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Table 1. Sites of CVADs about which questionnaire responses
were received
Site Responses received
Upper chest 60
Lower chest 13
Arm 3
Medial thigh 3
Total 79
Sites of Venous Access Ports 643children under 12 years of age, whose parents were
asked to complete questionnaires on their behalf.
Twenty eight patients had received one CVAD; 18
had two; four had three; three had four; and one
patient had seven—a total of 85 CVADs. Patients were
asked to complete a separate questionnaire for each
port but one patient who had had seven ports did not
do so: sites of the 79 CVADs about which responses
were received are shown in Table 1.
The questions are shown in Table 2. Patients were
asked to mark the sites of their CVADs on a picture of
the body, and a similar picture was used for marking
of the sites which they would choose for futures
CVADs.
Statistical comparisons were made between
CVADs on the upper chest and lower chest using
the Chi-squared test with Yates’ correction for
small numbers.Table 2. Questions posed in the questionnaire and responses for CV
Question Percentage
of positive
responses (%)
Uppe
No
Were you given a choice of sites for your port
to be implanted?
46 34
Have you had any problems with, or concern about, your port, for any
Cosmetic appearance (the way it looks) 44 33
Do you have an operation scar which you
dislike the look of?
44 35
Wearing own choice of clothes 42 35
Driving 14 47
Wearing a seat belt 51 26
Sports 19 48
Using your arm 16 53
Other activities 9 51
Lying in bed or sleeping 42 36
Your sex life 22 47
Your social life 20 48
Has your port been painful/uncomfortable 54 28
Placing needle in port by you (Most did not
respond)
12
Placing needle in port by nurse 22 46
Can you access the port yourself? 19 46
If No, would you like to be able to? 39 27
Do you flush your port yourself? 13 53
If No, would you like to be able to? 48 23
If you had to have another port, would you
choose to have it in the same place?
37 21Results
Table 2 shows the responses to questions for CVADs in
different sites. Statistical comparisons were done for
problems reported relating to CVADs implanted in the
upper chest versus the lower chest. None reached
statistical significance, but a numerical difference was
noted for trouble with lying in bed or sleeping—nine
of 12 (75%) in the lower chest compared with 24 of 60
(40%) in the upper chest. Cosmetic concerns were
reported in more than 40% responses (including
simple ‘cosmetic appearance’, dislike of the look of
the scar, and problems wearing the clothes patients
would choose). Some pain or discomfort was reported
for 54% CVADs.
Only 19% CVADs could be accessed by patients and
only 9% were flushed by patients, but in 48% cases
patients would have liked to flush the devices
themselves.
Patients reported that they had not been offered
choice of site before 64% CVAD insertions. In 37%
cases patients said that they would choose to have any
future CVAD in a different place. There was no
significant difference in the response to this question
by patients who had been given a choice (7 of 26) and
those who had not (10 of 24): note that these figures
apply to numbers of patients, not CVADs.ADs at different sites
r chest (60) Lower chest (13) Other (6) No
response
Yes No Yes No Yes
24 4 9 3 3 2
of these reasons? (If Yes, please give details):
27 5 8 6 0 0
25 5 8 4 2 0
25 6 7 5 1
7 8 2 5 1 9
34 7 6 6 0 0
10 8 2 4 2 5
7 9 4 4 2 0
6 13 0 4 1 4
24 3 9 6 0 1
11 6 3 4 2 6
11 5 4 6 0 5
32 5 7 2 4 1
6 1 1 3 1 54
13 11 2 3 2 2
12 13 0 3 3 1
19 8 5 2 0 18 ‘Yes’
7 13 0 3 3 0
27 8 5 3 0 13 ‘Yes’
36 4 6 2 4 6
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This study shows that choice was offered to patients
for the site of their CVADs in less than 50% cases, and
37% would not choose to have a CVAD placed in the
same site again. These figures may in fact reflect a
greater degree of choice than is generally found: one of
the authors (W.B.C.) routinely offered choice, and both
units implanted devices in a variety of sites. It may be
that many surgeons do not offer choice because they
cannot provide patients with information to guide
them, and lack of good data was a stimulus for
this study.
No significant differences were found between the
various sites for any of the specified problems or
concerns, but this may have been attributable to small
numbers. Finding a large cohort of patients with
prolonged experience of CVADs is difficult because
many devices are implanted in patients with limited
life expectancy due to cancer: this influenced the
choice of cystic fibrosis patients as the study group.
The responses showed that a substantial proportion of
patients (over 40%) disliked the cosmetic appearance
of their CVAD or the scar, and found themselves
limited in choice of clothing. This observation ought to
prompt discussion with patients about the proposed
site of their device, if only for cosmetic reasons.
The findings of the study also provide information
about common problems which should assist in
advising patients who are facing insertion of a CVAD
and in answering their questions. A study by Borst et
al.6 reported that a group of cancer patients had found
insertion of CVADs more painful than they had
expected. The present study showed that more than
half of the CVADs implanted on the chest had been
associated with pain or discomfort and 42% had
caused trouble lying in bed or sleeping. Problems
wearing a seatbelt affected 51% patients, and interest-
ingly this complaint was not confined to patients with
upper chest CVADs. Very few patients with upper
chest CVADs experienced trouble using their arm
(comparisons were attempted between right and left
upper chest, but numbers were too small).
The results also show that many more patients
would like to be able to access and flush their CVADsEur J Vasc Endovasc Surg Vol 28, December 2004than were able or permitted to do so in this study.
Training, and monitoring of good antiseptic technique
are essential if patients are to flush their CVADs
regularly. This may be a valuable investment of time,
allowing patients to become more responsible for their
own medical management.
Based on past experience it had been our prejudice
that CVADs on the lower chest were cosmetically more
acceptable to patients, and that they might interfere
less with activities such as wearing a seat belt or some
sports. These CVADs were generally sited somewhat
lateral to the midclavicular line, below the level of the
inframammary fold, over the lower ribs. We had also
observed that patients seem grateful for a discussion
about the site of their (or their child’s) CVAD before it
is inserted. Our findings suggest that patients’
cosmetic preferences are particularly important, but
larger numbers would be required to draw con-
clusions about possible differences between the var-
ious potential sites of CVAD placement. These results
should, however, alert clinicians to the fact that
concerns and problems are not uncommon for patients
with CVADs in a variety of sites.References
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